Bristol- Myers Squibb
A Financial Ratio Quarterly Trend Analysis of:
Bristol-Myers Squibb Company
Stock symbol: BMY
Listed on the New York Stock Exchange
Introduction:
The following report will include provide a financial quarterly trend analysis of Bristol-Myers Squibb Company (BMS) which was founded in 1989, and is based in New York City. This is a publicly traded company on the New York Stock Exchange (NYSE), and their stock symbol is BMY.
Bristol-Myers Squibb is currently “ranked 8th among 500 the largest United States”1 manufacturers. The company is “engaged in the discovery, development, licensing, manufacturing, distribution and sale of pharmaceutical products on a global basis.”2
The types of medications they produce help “fight against cancer, cardiovascular disease, diabetes, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.”3 Some of their more widely recognized medications include Abilify, Plavix, Reyataz, Coumadin, and Erbitux. The company is also heavily involved with genomics and biotechnology research and development.
I choose to analyze Bristol-Myers Squibb Company for the following reasons: • As an employee of the University of Miami Miller School of Medicine, I am very interested in the national concern regarding the practice of drug companies paying medical school faculty members and private practitioners thousands of dollars to speak about and basically promote their medical products. This is recognized as a blatant conflict of interest and has even been described as corruption. As the 8th largest U.S. pharmaceutical company, Bristol-Myers Squibb participates in this practice. • With the passing of the new Healthcare Reform Bill, the healthcare industry is going to be affected tremendously and the general public is and has been very concerned with the costs of medication. • Currently, there are major advances and discoveries being made in genomics and biotechnology. These are two areas in which Bristol-Myers Squibb
Bristol-Myers Squibb Company
Stock symbol: BMY
Listed on the New York Stock Exchange
Introduction:
The following report will include provide a financial quarterly trend analysis of Bristol-Myers Squibb Company (BMS) which was founded in 1989, and is based in New York City. This is a publicly traded company on the New York Stock Exchange (NYSE), and their stock symbol is BMY.
Bristol-Myers Squibb is currently “ranked 8th among 500 the largest United States”1 manufacturers. The company is “engaged in the discovery, development, licensing, manufacturing, distribution and sale of pharmaceutical products on a global basis.”2
The types of medications they produce help “fight against cancer, cardiovascular disease, diabetes, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.”3 Some of their more widely recognized medications include Abilify, Plavix, Reyataz, Coumadin, and Erbitux. The company is also heavily involved with genomics and biotechnology research and development.
I choose to analyze Bristol-Myers Squibb Company for the following reasons: • As an employee of the University of Miami Miller School of Medicine, I am very interested in the national concern regarding the practice of drug companies paying medical school faculty members and private practitioners thousands of dollars to speak about and basically promote their medical products. This is recognized as a blatant conflict of interest and has even been described as corruption. As the 8th largest U.S. pharmaceutical company, Bristol-Myers Squibb participates in this practice. • With the passing of the new Healthcare Reform Bill, the healthcare industry is going to be affected tremendously and the general public is and has been very concerned with the costs of medication. • Currently, there are major advances and discoveries being made in genomics and biotechnology. These are two areas in which Bristol-Myers Squibb
Bibliography: [5] Yahoo! Finance, http://finance.yahoo.com/q/bs?s=BMY&annual 2 Bristol-Myers Squibb Company Website: http://www.bms.com/ourcompany/Pages/home.aspx 3 Bristol-Myers Squibb Company Website: http://www.bms.com/ourcompany/Pages/home.aspx 4 New York Times, ttp://www.nytimes.com/2010/10/27/business/27pharma.html?ref=bristolmyerssquibbcompany 5 Market Watch, http://www.marketwatch.com/investing/Stock/BMY/financials/balance-sheet/quarter 6Bloomberg, http://www.bloomberg.com/apps/quote?ticker=BMY:US#chart 7 Morningstar, http://financials.morningstar.com/ratios/r.html?t=BMY®ion=USA&culture=en-us 8 NYT,http://markets.on.nytimes.com/research/stocks/fundamentals/financials.asp?symbol=&type=bs&period=q 9 Yahoo! Finance, http://finance.yahoo.com/q/bs?s=BMY&annual -----------------------